ILAE-Europe

EpiCARE designation of affiliated partners

EpiCARE -- a European Reference Network for Rare and Complex Epilepsies -- connects 28 expert centres in 13 Eruopean countries with the aim of aiding the diagnosis and treatment of rare epilepsy patients by using e-tools and cross-country e-consultance. EU member states without EpiCARE centres can nominate affiliated partners to join the network: EpiCARE Designation of affiliated partners

Award Winners Announced

ILAE-Europe is pleased to announce the recipients of the European Awards 2018. The awards were presented during the Welcome Ceremony of the 13th ECE on Sunday 26th August.

Emilio Perucca
Emilio Perucca (Italy), European Epileptology Award

European Epileptology Award - Emilio Perucca (Italy)

European Young Investigator Award - Birgit Frauscher (Austria/Canada)

European Young Investigator Award - Sylvain Rheims (France)

European Epilepsy Education Award - Kristina Malmgren (Sweden)

European Epilepsy Service Award - Finola Quinn (Ireland)

2020 Course Applications

European Chapter Executives are invited to submit applications for funding of courses/symposia sponsored by ILAE-Europe during 2020.

Read letter to European Chapters

Procedure for endorsing meetings not organized by ILAE

Application for endorsement of meetings by ILAE

ILAE Learning Objectives Matrix

Visiting Professor Application

ILAE Learning Objectives Matrix

Latest News

Jerzy Majkowski
About ILAE

In memoriam Jerzy Majkowski

We are deeply saddened to announce that Jerzy Majkowski Emeritus Professor of Neurology and father of the Polish League Against Epilepsy, passed away on July 18 2019 in Warsaw at age 91. He contributed much in area of neurophysiology and epileptology. He trained and inspired a large number of…

31 July, 2019
Nature Reviews Neurology
Clinical Research

Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy

In this Review, we focus on our understanding of the IL-1 receptor–Toll-like receptor 4 axis, the arachidonic acid–prostaglandin cascade, oxidative stress and transforming growth factor-β signalling associated with blood–brain barrier dysfunction, all of which are pathways that are activated in pharmacoresistant epilepsy in humans and that can be modulated in animal models to produce therapeutic effects on seizures, neuronal cell loss and neurological comorbidities.

30 July, 2019

View All Commission News